POC PLATFORM AND TECHNOLOGY MARKET ANALYSIS

POC Platform and Technology Market, by Technology (Lateral Flow Based Assays (Colloidal Gold Label, Colored Latex Particle Label, Paramagnetic Monodisperse Latexes, and Fluorescence Immunoassay), Enzyme Labels, Microfluidics, Biochips, Biosensors, Medical MEMS, Agglutination, Solid Phase, Lab-on-a-chip, and Chemiluminescence Based Systems), by Application (Diagnostic Testing & Monitoring and Drug Development & Quality Testing), by End User (Hospitals, Clinics, Laboratories, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Feb 2022
Code : CMI1501
Pages :202
Formats :
Excel and PDF
Industry : Medical Devices

Market News

For instance, in January 2018, Atomo Diagnostics, an Australian company, entered into a strategic collaboration with Access Bio, a company committed to the early diagnosis and prevention of infectious diseases. This partnership aims to enlarge access to best-in-class HIV rapid testing in global market.

For instance, in March 2018, SenzaGen, focused on performing and selling state-of-the-art non-animal tests for assessing a substance’s allergenicity, signed a key license agreement with Burlesson Research Technologies, Inc., (BRT) a contract research organization in the U.S., specializing in POC toxicology devices.

For instance, in December 2020, Abbott Laboratories, a U.S. based multinational medical devices and health care company, received the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for virtually guided BinaxNOW COVID-19 Ag Card rapid test for COVID-19 infection detection. It is affordable, reliable, and rapid testing method.